Shahram Hejazi, PhD, Managing Director

Terese Bogucki, Principal

Rae Chu-Colwell, Associate

Shahram Hejazi PhD, Managing Director

Dr. Shahram Hejazi is a medical device/life science executive with general management experience in both early-stage ventures and large global companies. He is a currently a Venture Partner with BioAdvance - an early-stage investment firm - where he is responsible for investments in medial device, diagnostics and molecular imaging.

Previously, Dr. Hejazi was the President of Kodak's life science division (now called Carestream Molecular Imaging), where he had global responsibility for R&D, manufacturing, operations, sales, marketing and service. While holing this position, Dr. Hejazi led the system business to successful double-digit annual growth and directed the launch of a new imaging agent business.

Before Kodak, he was the CEO of Zargis Medical Corp. (an early stage medical device company that spun-off from Siemens) where he led the company from raising capital and technology development to completion of several clinical trials, FDA approval, and product launch. Prior to Zargis, Dr. Hejazi was the Head of the Strategic Business Development group at Siemens, where he was responsible for identifying early stage growth/investment opportunities and new business development in the medical field. Earlier in his career, Dr. Hejazi held R&D management positions within the diagnostic imaging and nanotechnology fields at Kodak and IBM.

Dr. Hejazi has authored over 10 scientific publications and has been interviewed by several professional journals on topics related to molecular imaging/diagnostics. He is an FDA Industry Advisory Panel Member for Molecular and Clinical Genetic Devices, and serves on the boards of Bioscan Inc., SibTech Inc., Fox Chase Cancer Center (advisory), and Alpha Innotech Inc. (2009). Dr. Hejazi has a PhD in engineering with emphasis in biophysics from the University at Buffalo SUNY, and executive business education from Stanford University.